Bee Venum injections
Bee Venum injections
2300
post-template-default,single,single-post,postid-2300,single-format-standard,ajax_fade,page_not_loaded,,qode-theme-ver-7.4,wpb-js-composer js-comp-ver-4.5.2,vc_responsive
 

Using Bee Venum injections to treat chronic lyme disease.

22 Jun Using Bee Venum injections to treat chronic lyme disease.

It is relatively painless and has an incredible effect in Lyme Disease patients.

In some it lasts for 2 days and in others for 3-4 days. Dependent on the response we establishes a schedule: shots every 3-4 days.  It appears to be a great benefit!

Below is an interesting study on the powerful effects of bee venom on Lyme Disease:

Clin Infect Dis 1997 Jul;25 Suppl 1:S48-51

The antimicrobial agent melittin exhibits powerful in vitro inhibitory effects on the Lyme disease spirochete.

Lubke LL, Garon CF

Rocky Mountain Laboratories Microscopy Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana 59840, USA.

Borrelia burgdorferi has demonstrated a capacity to resist the in-vitro effects of powerful eukaryotic and prokaryotic metabolic inhibitors. However, treatment of laboratory cultures on Barbour-Stoenner-Kelly medium with melittin, a 26-amino acid peptide contained in honeybee venom, showed immediate and profound inhibitory effects when they were monitored by darkfield microscopy, field emission scanning electron microscopy, and optical density measurements.

Furthermore, at melittin concentrations as low as 100 microg/mL, virtually all spirochete motility ceased within seconds of inhibitor addition. Ultrastructural examination of these spirochetes by scanning electron microscopy revealed obvious alterations in the surface envelope of the spirochetes. The extraordinary sensitivity of B. burgdorferi to mellitin may provide both a research reagent useful in the study of selective permeability in microorganisms and important clues to the development of effective new drugs against lyme disease.

No Comments

Post A Comment

Consultation Request for New Patients